The Type II Diabetes drug, Actos has received a black box label, has had a label change warning of a 40% increase in the risk for bladder cancer, and has been banned in France and Germany. Yet, Actos still remains on the market in the United States. Ringler Radio, host Larry Cohen joins colleague Martin...
|
|
Ringler Radio |
Larry Cohen is the host of Ringler Radio and is the head of Ringler Associates operations in the Northeast....
The Type II Diabetes drug, Actos has received a black box label, has had a label change warning of a 40% increase in the risk for bladder cancer, and has been banned in France and Germany. Yet, Actos still remains on the market in the United States. Ringler Radio, host Larry Cohen joins colleague Martin C. Blount and Attorney Michael J. Miller, from The Miller Firm LLC, to discuss the side effects of the diabetes medication Actos, including its connection to bladder cancer, reaction of the FDA, and recent litigation.
Visit Ringler Associates to contact a consultant in your area about structured settlements.
| Published: | May 30, 2012 |
| Podcast: | Ringler Radio |
|
|
Ringler Radio |
Ringler Radio presents an unprecedented analysis of the latest news impacting the structured settlement profession.
Paul Marshall, Sales Director of Structured Settlements for MetLife, discusses MetLife’s NQA product, the types of cases that are included under NQA eligibility, and...
Patrick Haines discusses pending litigation and next steps for the victims of this disaster.
Attorney Dan Wade, coordinator of the Disaster Legal Services Program, and Alia S. Graham, program specialist for the ABA's Young Lawyers Division, talk about...
Tax attorney Robert Wood discusses the tax implications of structuring a settlement in a non-qualified case such as divorce, disability, or environmental versus taking...
Larry Cohen welcomes co-host Cindy Chanley and returning guest, tax attorney Robert Wood from Wood LLP, to explore the arena of non-qualified settlements and...
A San Francisco federal judge gave the green light for hundreds of lawsuits to go forward claiming Monsanto's popular glyphosate weed killer, Roundup, causes...